ReviewMini reviews in medicinal chemistry2026

Inavolisib-based Combination Therapy for the Treatment of PIK3CAMutated HR+/HER2- Breast Cancer: An Overview.

Sushmita Bhatia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.